|
gptkbp:instanceOf
|
Sleep disorder
|
|
gptkbp:affects
|
gptkb:Humans
|
|
gptkbp:associatedWith
|
gptkb:HLA-DQB1*06:02_allele
gptkb:HLA_complex
gptkb:T-cell_receptor_alpha_locus
|
|
gptkbp:cause
|
Loss of hypocretin-producing neurons
|
|
gptkbp:complication
|
Obesity
Depression
|
|
gptkbp:diagnosedBy
|
gptkb:Polysomnography
Multiple sleep latency test
|
|
gptkbp:differentialDiagnosis
|
gptkb:Idiopathic_hypersomnia
gptkb:Obstructive_sleep_apnea
Seizure disorders
|
|
gptkbp:field
|
Neurology
Sleep medicine
|
|
gptkbp:firstDescribed
|
gptkb:Jean-Baptiste-Édouard_Gélineau
1880
|
|
gptkbp:frequency
|
Rare
|
|
gptkbp:hasAwarenessDay
|
gptkb:March_11_(World_Narcolepsy_Day)
|
|
gptkbp:hasType
|
gptkb:Narcolepsy_type_1
gptkb:Narcolepsy_type_2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Narcolepsy
|
|
gptkbp:ICD-10_code
|
gptkb:G47.4
|
|
gptkbp:MeSH_ID
|
gptkb:D009290
|
|
gptkbp:notableCase
|
gptkb:Stanford_University_Sleep_Clinic
|
|
gptkbp:OMIM
|
161400
|
|
gptkbp:onset
|
Usually begins in adolescence or young adulthood
|
|
gptkbp:prevalence
|
Affects about 1 in 2,000 people
|
|
gptkbp:riskFactor
|
Genetic predisposition
Autoimmune factors
|
|
gptkbp:symptom
|
gptkb:Cataplexy
gptkb:Hypnagogic_hallucinations
Excessive daytime sleepiness
Sleep paralysis
|
|
gptkbp:treatment
|
gptkb:Antidepressants
gptkb:Sodium_oxybate
Stimulant medications
|
|
gptkbp:bfsParent
|
gptkb:Polysomnography
gptkb:Ben_Folds
gptkb:Sleep_disorder
|
|
gptkbp:bfsLayer
|
6
|